Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,334 across all filing types
Latest filing 2020-11-02 Declaration of Voting R…
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a notification released via RNS (London Stock Exchange news service) on November 2, 2020. The content explicitly states it is a 'Transparency Directive' notification regarding 'Voting rights and capital'. It provides the total number of voting rights (1,312,307,462) as of October 31, 2020, which is used by shareholders to calculate their required disclosures under the Disclosure and Transparency Rules. This type of regulatory update concerning the total number of shares with voting rights fits best under the general regulatory announcement category, RNS, as it is not a specific financial report (like 10-K or IR) or a specific corporate action like a dividend or share repurchase. While it relates to capital structure, it is a mandatory disclosure of voting rights denominator, making RNS the most appropriate general regulatory filing code.
2020-11-02 English
ATACAND TO BE DIVESTED TO CHEPLAPHARM IN MORE THAN 70 COUNTRIES
Foreign Filer Report
2020-10-30 English
Atacand to be divested in more than 70 countries
Regulatory Filings Classification · 98% confidence The document is clearly identified as an 'RNS Number' filing from AstraZeneca PLC, dated October 30, 2020. RNS stands for Regulatory News Service, which is the primary channel for official announcements to the London Stock Exchange. The content describes a specific corporate action: the divestment of commercial rights for the drug Atacand to Cheplapharm for $400m. This is a material corporate event announcement. Since it is a general regulatory announcement that doesn't fit perfectly into specific categories like M&A (TAR) or Capital Change (CAP), and it is explicitly labeled as an RNS release, the most appropriate classification is the general Regulatory Filings category (RNS). The document length (5668 chars) is substantial enough that it is the announcement itself, not just a pointer to a larger document.
2020-10-30 English
DIRECTORATE CHANGE
Foreign Filer Report
2020-10-29 English
Directorate Change
Board/Management Information Classification · 98% confidence The document is an official announcement disseminated via RNS (Regulatory News Service), indicated by the 'RNS Number' and the closing footer mentioning RNS and the London Stock Exchange. The core content announces the appointment of a new Non-Executive Director, Diana Layfield, effective November 1, 2020. This type of announcement—a change in the company's board of directors or senior management—directly corresponds to the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific content is highly targeted, making MANG the most accurate classification over the general RNS fallback.
2020-10-29 English
ENHERTU GRANTED PRIORITY REVIEW IN THE US FOR THE TREATMENT OF HER2-POSITIVE MET
Foreign Filer Report
2020-10-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.